Germany Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers
Germany Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers is a market research report published by Renub Research. According to this report Germany Proton Therapy Industry has a market potential of US$ 2 Billion by 2021. Currently Germany has 6 operational proton therapy centers. Rising cancer incidence in Germany is the major key driver to boost Germany proton therapy market. Adoption of technological up-gradation that has more utilization rate will shorten the length of time per patient.
In this report we have studied the market in two parts a) Actual Market and b) Untapped Market. The report also talks about list of all operational and Future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies ( IBA, Varian Medical Systems, Elekta) has been studied in the report.
Note: Actual Market is the current market which is already present
Untapped Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.
Germany Proton Therapy Market has been analyzed from four view points
1. IBA (Overview, Sales Analysis)
2. Varian Medical Systems (Overview, Sales Analysis)
3. Elekta (Overview, Sales Analysis)
Key Questions Answered in the Report?
In this report we have studied the market in two parts a) Actual Market and b) Untapped Market. The report also talks about list of all operational and Future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies ( IBA, Varian Medical Systems, Elekta) has been studied in the report.
Note: Actual Market is the current market which is already present
Untapped Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.
Germany Proton Therapy Market has been analyzed from four view points
- Germany Proton Therapy Actual Market & Forecast (2009 – 2021)
- Germany Proton Therapy Untapped Market & Forecast (2009 – 2021)
- Germany Proton Therapy Treated Patient Volume & Forecast (2009 – 2021)
- Germany Proton Therapy Untapped Patient Volume & Forecast (2009 – 2021)
1. IBA (Overview, Sales Analysis)
2. Varian Medical Systems (Overview, Sales Analysis)
3. Elekta (Overview, Sales Analysis)
Key Questions Answered in the Report?
- What are Germany Proton Therapy Market and its Future Potential?
- What is the Proton Therapy Potential Market in Germany and its Future?
- What is Number of Proton Therapy Centers operating in Germany?
- What is the Number of People being treated in these Proton Therapy Centers yearly?
- What are Proton Therapy Reimbursements policies of Germany?
- What are the sales of Proton Therapy Companies Globally (IBA, Varian, Elekta)?
1. EXECUTIVE SUMMARY
2. FRANCE PROTON THERAPY MARKET – ACTUAL & UNTAPPED MARKET
2.1 France – Proton Therapy Market & Forecast
2.2 France – Untapped Proton Therapy Market
3. FRANCE PROTON THERAPY PATIENTS – ACTUAL & UNTAPPED NUMBER OF PATIENTS
3.1 France – Patient Treated with Proton Therapy Numbers & Forecast
3.2 France – Untapped Patients for Proton Therapy
4. FRANCE – LIST OF PROTON THERAPY CENTERS (OPERATING AND UNDER-CONSTRUCTION) FACILITIES
5. FRANCE – PROTON THERAPY TREATED PATIENTS BY CENTERS
5.1 Nice (CAL) Proton Therapy Center – Number of Patients Treated (2008 – 2015)
5.2 Orsay (CPO) Proton Therapy Center – Number of Patients Treated (2008 – 2015)
6. PROTON THERAPY – REIMBURSEMENT POLICIES
6.1 Proton Therapy Reimbursement Policies for Patients
6.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers
7. COMPONENTS OF A STANDARD PROTON THERAPY CENTER
7.1 Proton Accelerator
7.1.1 Synchrotrons (example: LLUMC at Loma Linda)
7.1.2 Cyclotrons (example: MGH Boston)
7.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
7.1.4 Linacs (Rome)
7.1.5 H-minus Synchrotrons
7.1.6 Separated Sector Cyclotrons
7.1.7 Super-conducting Cyclotrons
7.1.8 Fast Cycling Synchrotron
7.2 Beam Transport System
7.3 Beam Delivery System
7.3.1 The Passive Scattering Technique
7.3.2 Beam Scanning
7.4 Nozzle
7.4.1 Single Scattering
7.4.2 Double Scattering
7.4.3 Uniform Scanning Nozzle
7.4.4 Pencil Scanning Nozzle
7.5 Treatment Planning System
7.6 Image Viewers
7.7 Patient Positioning System (PPS)
7.8 Human Resource
8. GLOBAL PROTON THERAPY - COMPANY ANALYSIS (2010 – 2021)
8.1 IBA Proton Therapy
8.1.1 Sales Analysis
8.2 Varian Medical Systems
8.2.1 Sales Analysis
8.3 Elekta
8.3.1 Sales Analysis
9. PROTON THERAPY – DRIVING FACTORS
9.1 Technology Advancement
9.2 Growing Incidence of Cancer Patients in France
10. PROTON THERAPY – CHALLENGES
10.1 Requires Huge Investment
10.2 Operations Challenges
2. FRANCE PROTON THERAPY MARKET – ACTUAL & UNTAPPED MARKET
2.1 France – Proton Therapy Market & Forecast
2.2 France – Untapped Proton Therapy Market
3. FRANCE PROTON THERAPY PATIENTS – ACTUAL & UNTAPPED NUMBER OF PATIENTS
3.1 France – Patient Treated with Proton Therapy Numbers & Forecast
3.2 France – Untapped Patients for Proton Therapy
4. FRANCE – LIST OF PROTON THERAPY CENTERS (OPERATING AND UNDER-CONSTRUCTION) FACILITIES
5. FRANCE – PROTON THERAPY TREATED PATIENTS BY CENTERS
5.1 Nice (CAL) Proton Therapy Center – Number of Patients Treated (2008 – 2015)
5.2 Orsay (CPO) Proton Therapy Center – Number of Patients Treated (2008 – 2015)
6. PROTON THERAPY – REIMBURSEMENT POLICIES
6.1 Proton Therapy Reimbursement Policies for Patients
6.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers
7. COMPONENTS OF A STANDARD PROTON THERAPY CENTER
7.1 Proton Accelerator
7.1.1 Synchrotrons (example: LLUMC at Loma Linda)
7.1.2 Cyclotrons (example: MGH Boston)
7.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
7.1.4 Linacs (Rome)
7.1.5 H-minus Synchrotrons
7.1.6 Separated Sector Cyclotrons
7.1.7 Super-conducting Cyclotrons
7.1.8 Fast Cycling Synchrotron
7.2 Beam Transport System
7.3 Beam Delivery System
7.3.1 The Passive Scattering Technique
7.3.2 Beam Scanning
7.4 Nozzle
7.4.1 Single Scattering
7.4.2 Double Scattering
7.4.3 Uniform Scanning Nozzle
7.4.4 Pencil Scanning Nozzle
7.5 Treatment Planning System
7.6 Image Viewers
7.7 Patient Positioning System (PPS)
7.8 Human Resource
8. GLOBAL PROTON THERAPY - COMPANY ANALYSIS (2010 – 2021)
8.1 IBA Proton Therapy
8.1.1 Sales Analysis
8.2 Varian Medical Systems
8.2.1 Sales Analysis
8.3 Elekta
8.3.1 Sales Analysis
9. PROTON THERAPY – DRIVING FACTORS
9.1 Technology Advancement
9.2 Growing Incidence of Cancer Patients in France
10. PROTON THERAPY – CHALLENGES
10.1 Requires Huge Investment
10.2 Operations Challenges
LIST OF FIGURES
Figure 2 1: France – Proton Therapy Market (Million US$), 2009 – 2016
Figure 2 2: France – Forecast for Proton Therapy Market (Million US$), 2017 – 2021
Figure 2 3: France – Untapped Proton Therapy Market (Million US$), 2009 – 2016
Figure 2 4: France – Forecast for Untapped Proton Therapy Market (Million US$), 2017 – 2021
Figure 3 1: France – Patient Treated with Proton Therapy (Number), 2009 – 2016
Figure 3 2: France – Forecast for Patient Treated with Proton Therapy (Number), 2017 – 2021
Figure 3 3: France – Untapped Patients for Proton Therapy (Number), 2009 – 2016
Figure 3 4: France – Forecast for Untapped Patients for Proton Therapy (Number), 2017 – 2021
Figure 8 1: Global – IBA Proton Therapy Sales (Million US$), 2010 – 2016
Figure 8 2: Global – Forecast for IBA Proton Therapy Sales (Million US$), 2017 – 2021
Figure 8 3: Global – Varian Medical Systems Oncology Systems Sales (Million US$), 2010 – 2016
Figure 8 4: Global – Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2017 – 2021
Figure 8 5: Global – Elekta Radiation Technology Sales (Million US$), 2010 – 2016
Figure 8 6: Global – Forecast for Elekta Radiation Technology Sales (Million US$), 2017 – 2021
Figure 9 1: France – Number of Patient Diagnosed With Cancer (Thousand), 2009 – 2016
Figure 9 2: France – Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2017 – 2021
Figure 2 1: France – Proton Therapy Market (Million US$), 2009 – 2016
Figure 2 2: France – Forecast for Proton Therapy Market (Million US$), 2017 – 2021
Figure 2 3: France – Untapped Proton Therapy Market (Million US$), 2009 – 2016
Figure 2 4: France – Forecast for Untapped Proton Therapy Market (Million US$), 2017 – 2021
Figure 3 1: France – Patient Treated with Proton Therapy (Number), 2009 – 2016
Figure 3 2: France – Forecast for Patient Treated with Proton Therapy (Number), 2017 – 2021
Figure 3 3: France – Untapped Patients for Proton Therapy (Number), 2009 – 2016
Figure 3 4: France – Forecast for Untapped Patients for Proton Therapy (Number), 2017 – 2021
Figure 8 1: Global – IBA Proton Therapy Sales (Million US$), 2010 – 2016
Figure 8 2: Global – Forecast for IBA Proton Therapy Sales (Million US$), 2017 – 2021
Figure 8 3: Global – Varian Medical Systems Oncology Systems Sales (Million US$), 2010 – 2016
Figure 8 4: Global – Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2017 – 2021
Figure 8 5: Global – Elekta Radiation Technology Sales (Million US$), 2010 – 2016
Figure 8 6: Global – Forecast for Elekta Radiation Technology Sales (Million US$), 2017 – 2021
Figure 9 1: France – Number of Patient Diagnosed With Cancer (Thousand), 2009 – 2016
Figure 9 2: France – Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2017 – 2021
LIST OF TABLES
Table 4 1: France – Proton Therapy Facilities in Operation and Under-Construction
Table 5 1: France – Nice (CAL) Proton Therapy Center with Patients Treated (Number), 2008 – 2015
Table 5 2: France – Orsay (CPO) Proton Therapy Center with Patients Treated (Number), 2008 – 2015
Table 4 1: France – Proton Therapy Facilities in Operation and Under-Construction
Table 5 1: France – Nice (CAL) Proton Therapy Center with Patients Treated (Number), 2008 – 2015
Table 5 2: France – Orsay (CPO) Proton Therapy Center with Patients Treated (Number), 2008 – 2015
